Tags

Type your tag names separated by a space and hit enter

Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries.
PLoS Med. 2019 06; 16(6):e1002824.PM

Abstract

In a Perspective for the Tuberculosis Special Issue, Kevin Schwartzman and colleagues discuss the choices and implications for personal versus public health benefits when pursuing tuberculosis elimination in low-incidence countries.

Authors+Show Affiliations

McGill International TB Centre, McGill University, Montréal, Québec, Canada. Respiratory Epidemiology and Clinical Research Unit, Montréal Chest Institute, McGill University Health Centre, Montréal, Québec, Canada.Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.McGill International TB Centre, McGill University, Montréal, Québec, Canada. Respiratory Epidemiology and Clinical Research Unit, Montréal Chest Institute, McGill University Health Centre, Montréal, Québec, Canada.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

31170161

Citation

Campbell, Jonathon R., et al. "Treatment of Latent Infection to Achieve Tuberculosis Elimination in Low-incidence Countries." PLoS Medicine, vol. 16, no. 6, 2019, pp. e1002824.
Campbell JR, Dowdy D, Schwartzman K. Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries. PLoS Med. 2019;16(6):e1002824.
Campbell, J. R., Dowdy, D., & Schwartzman, K. (2019). Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries. PLoS Medicine, 16(6), e1002824. https://doi.org/10.1371/journal.pmed.1002824
Campbell JR, Dowdy D, Schwartzman K. Treatment of Latent Infection to Achieve Tuberculosis Elimination in Low-incidence Countries. PLoS Med. 2019;16(6):e1002824. PubMed PMID: 31170161.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries. AU - Campbell,Jonathon R, AU - Dowdy,David, AU - Schwartzman,Kevin, Y1 - 2019/06/06/ PY - 2019/6/7/entrez PY - 2019/6/7/pubmed PY - 2019/12/4/medline SP - e1002824 EP - e1002824 JF - PLoS medicine JO - PLoS Med VL - 16 IS - 6 N2 - In a Perspective for the Tuberculosis Special Issue, Kevin Schwartzman and colleagues discuss the choices and implications for personal versus public health benefits when pursuing tuberculosis elimination in low-incidence countries. SN - 1549-1676 UR - https://www.unboundmedicine.com/medline/citation/31170161/Treatment_of_latent_infection_to_achieve_tuberculosis_elimination_in_low_incidence_countries_ L2 - https://dx.plos.org/10.1371/journal.pmed.1002824 DB - PRIME DP - Unbound Medicine ER -